These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20878421)
41. New and traditional serum markers of bone metabolism in the detection of skeletal metastases. Plebani M; Bernardi D; Zaninotto M; De Paoli M; Secchiero S; Sciacovelli L Clin Biochem; 1996 Feb; 29(1):67-72. PubMed ID: 8929827 [TBL] [Abstract][Full Text] [Related]
42. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M; Fukunaga M; Ohtawa T; Harada T World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [TBL] [Abstract][Full Text] [Related]
43. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693 [TBL] [Abstract][Full Text] [Related]
44. Bone Metabolism, Bone Mineral Content, and Density in Elite Late Teen Female Sprinters. Tsukahara Y; Torii S; Yamasawa F; Iwamoto J; Otsuka T; Goto H; Kusakabe T; Matsumoto H; Akama T Int J Sports Med; 2021 Dec; 42(13):1228-1233. PubMed ID: 34015835 [TBL] [Abstract][Full Text] [Related]
45. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743 [TBL] [Abstract][Full Text] [Related]
46. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. Woitge HW; Knothe A; Witte K; Schmidt-Gayk H; Ziegler R; Lemmer B; Seibel MJ J Bone Miner Res; 2000 Dec; 15(12):2443-50. PubMed ID: 11127208 [TBL] [Abstract][Full Text] [Related]
47. Effect of vitamin D fortified foods on bone markers and muscle strength in women of Pakistani and Danish origin living in Denmark: a randomised controlled trial. Grønborg IM; Tetens I; Andersen EW; Kristensen M; Larsen REK; Tran TLL; Andersen R Nutr J; 2019 Dec; 18(1):82. PubMed ID: 31791333 [TBL] [Abstract][Full Text] [Related]
48. Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus. Park H; Brannon PM; West AA; Yan J; Jiang X; Perry CA; Malysheva O; Mehta S; Caudill MA Bone; 2017 Feb; 95():183-191. PubMed ID: 27939956 [TBL] [Abstract][Full Text] [Related]
49. Bone turnover in children with vitamin D deficiency rickets before and during treatment. Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183 [TBL] [Abstract][Full Text] [Related]
50. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture. Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133 [TBL] [Abstract][Full Text] [Related]
51. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170 [TBL] [Abstract][Full Text] [Related]
52. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661 [TBL] [Abstract][Full Text] [Related]
53. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis]. Miura M Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933 [TBL] [Abstract][Full Text] [Related]
54. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy. Azizi G; Hansen A; Prestwood KM Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800 [TBL] [Abstract][Full Text] [Related]
55. Role of biochemical markers of bone remodeling in clinical practice. Camozzi V; Tossi A; Simoni E; Pagani F; Francucci CM; Moro L J Endocrinol Invest; 2007; 30(6 Suppl):13-7. PubMed ID: 17721068 [TBL] [Abstract][Full Text] [Related]
56. Usefulness of bone resorption markers in hemodialysis patients. Hamano T; Tomida K; Mikami S; Matsui I; Fujii N; Imai E; Rakugi H; Isaka Y Bone; 2009 Jul; 45 Suppl 1():S19-25. PubMed ID: 19332165 [TBL] [Abstract][Full Text] [Related]
57. Biological variation in bone-derived biochemical markers in serum. Panteghini M; Pagani F Scand J Clin Lab Invest; 1995 Nov; 55(7):609-16. PubMed ID: 8633185 [TBL] [Abstract][Full Text] [Related]
58. Bone remodelling markers in rheumatoid arthritis. Fardellone P; Séjourné A; Paccou J; Goëb V Mediators Inflamm; 2014; 2014():484280. PubMed ID: 24839355 [TBL] [Abstract][Full Text] [Related]
59. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501 [TBL] [Abstract][Full Text] [Related]
60. Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data. Lenora J; Gerdhem P; Obrant KJ; Ivaska KK Osteoporos Int; 2009 Jul; 20(7):1225-32. PubMed ID: 18949532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]